Corgenix partners with Fio Corp. to fight Ebola virus
DENVER - Corgenix Medical Corp . (OTC QB: CONX.OB) and Fio Corp. announced the two companies are working together to integrate two technological advances to help end the Ebola outbreak in... Read More
Wednesday March 11, 2015 0 comments
Corgenix receives FDA approval for emergency use of its ReEBOV Ebola rapid detection test
BROOMFIELD - Corgenix Medical Corp. (OTC QB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, announced it received FDA emergency use authorization for its ReEBOV Antigen... Read More
Thursday February 26, 2015 0 comments
Corgenix awarded $818K to develop Ebola rapid diagnostic field test kit
DENVER - Corgenix Medical Corporation (OTCQB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, announced it has been awarded two grants totaling $818,000 to advance the... Read More
Friday December 26, 2014 0 comments
Corgenix agrees to be acquired by Orgentec Diagnostika for $16M
DENVER - Corgenix Medical Corp. (OTC QB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, announced it has agreed to be acquired by Orgentec Diagnostika , a German... Read More
Friday August 29, 2014 0 comments
Corgenix working on Ebola test kit but likely won't be ready for current outbreak
BROOMFIELD - Corgenix Medical Corp. (OTCBB: CONX) announced it is working to develop a diagnostic test kit for the Ebola virus but won't likely be able to provide the kit for the current... Read More
Tuesday August 12, 2014 0 comments
Corgenix research group announces NIH grant to advance Ebola rapid diagnostic test kit
DENVER -- Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million National Institutes of... Read More
Friday June 27, 2014 0 comments
Corgenix announces CE Mark notification for TxBCardio Assay
DENVER -- Corgenix Medical Corporation (OTC BB: CONX.OB) announced in collaboration with UK-based Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio™... Read More
Friday May 16, 2014 0 comments
Corgenix extending viral hemorrhagic fever rapid test to include Ebola to address African outbreak
DENVER - An outbreak of deadly Ebola virus in West Africa has prompted Denver-based Corgenix Medical Corp. (OTCBB: CONX) to extend its existing viral hemorrhagic fever (VHF) rapid test... Read More
Tuesday April 1, 2014 0 comments
- 1
- 2
IN Sponsors
Browse
Entrepreneurial by Nature
